Friedrich-reinhard Graf Finck Von Finckenstein

1 Patent

• US125530292026

  Treatment of NSCLC Patients with Tumor Infiltrating Lymphocyte Therapies

  Iovance Biotherapeutics, Inc.

  0 cites